These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23799599)

  • 1. [Metabolomics in ischaemic stroke, new diagnostic and prognostic biomarkers].
    Mauri-Capdevila G; Jove M; Suarez-Luis I; Portero-Otin M; Purroy F
    Rev Neurol; 2013 Jul; 57(1):29-36. PubMed ID: 23799599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomics of ischemic stroke: insights into risk prediction and mechanisms.
    Zhang R; Meng J; Wang X; Pu L; Zhao T; Huang Y; Han L
    Metab Brain Dis; 2022 Oct; 37(7):2163-2180. PubMed ID: 35612695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical Application of Biogenic Amine Profiles for the Diagnosis of Patients with Ischemic Stroke.
    Miękus N; Olędzka I; Kowalski P; Miękus P; Baczek T
    J Stroke Cerebrovasc Dis; 2018 Apr; 27(4):945-950. PubMed ID: 29221970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Emerging Role of Metabolomics in the Diagnosis and Prognosis of Cardiovascular Disease.
    Ussher JR; Elmariah S; Gerszten RE; Dyck JR
    J Am Coll Cardiol; 2016 Dec; 68(25):2850-2870. PubMed ID: 28007146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomics facilitates the discovery of metabolic biomarkers and pathways for ischemic stroke: a systematic review.
    Ke C; Pan CW; Zhang Y; Zhu X; Zhang Y
    Metabolomics; 2019 Nov; 15(12):152. PubMed ID: 31754808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. System-wide assembly of pathways and modules hierarchically reveal metabolic mechanism of cerebral ischemia.
    Zhu Y; Guo Z; Zhang L; Zhang Y; Chen Y; Nan J; Zhao B; Xiao H; Wang Z; Wang Y
    Sci Rep; 2015 Dec; 5():17068. PubMed ID: 26621314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomics and metabolites in ischemic stroke.
    Chumachenko MS; Waseem TV; Fedorovich SV
    Rev Neurosci; 2022 Feb; 33(2):181-205. PubMed ID: 34213842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomics and the diagnosis of human diseases--a guide to the markers and pathophysiological pathways affected.
    Medina S; Dominguez-Perles R; Gil JI; Ferreres F; Gil-Izquierdo A
    Curr Med Chem; 2014 Mar; 21(7):823-48. PubMed ID: 24251573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Evidence-Based Review of Related Metabolites and Metabolic Network Research on Cerebral Ischemia.
    Liu M; Tang L; Liu X; Fang J; Zhan H; Wu H; Yang H
    Oxid Med Cell Longev; 2016; 2016():9162074. PubMed ID: 27274780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of targeted metabolomics: dominance-based rough set approach versus orthogonal partial least square-discriminant analysis.
    Blasco H; Błaszczyński J; Billaut JC; Nadal-Desbarats L; Pradat PF; Devos D; Moreau C; Andres CR; Emond P; Corcia P; Słowiński R
    J Biomed Inform; 2015 Feb; 53():291-9. PubMed ID: 25499899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomics in cardiovascular diseases.
    Kordalewska M; Markuszewski MJ
    J Pharm Biomed Anal; 2015 Sep; 113():121-36. PubMed ID: 25958299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometry-based metabolomics: applications to biomarker and metabolic pathway research.
    Zhang A; Sun H; Yan G; Wang P; Wang X
    Biomed Chromatogr; 2016 Jan; 30(1):7-12. PubMed ID: 25739660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advantages and Limitations of Current Biomarker Research: From Experimental Research to Clinical Application.
    Kim SH; Weiß C; Hoffmann U; Borggrefe M; Akin I; Behnes M
    Curr Pharm Biotechnol; 2017; 18(6):445-455. PubMed ID: 28571562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states.
    Stenzel-Poore MP; Stevens SL; Xiong Z; Lessov NS; Harrington CA; Mori M; Meller R; Rosenzweig HL; Tobar E; Shaw TE; Chu X; Simon RP
    Lancet; 2003 Sep; 362(9389):1028-37. PubMed ID: 14522533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection and dynamic metabolic response of rat biomarkers by metabonomics and multivariate statistical analysis combined with GC-MS.
    Gao X; Guo B; Yang L; Liu J; Zhang X; Qin X; Du G
    Pharmacol Biochem Behav; 2014 Feb; 117():85-91. PubMed ID: 24355550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members.
    Di Napoli M; Schwaninger M; Cappelli R; Ceccarelli E; Di Gianfilippo G; Donati C; Emsley HC; Forconi S; Hopkins SJ; Masotti L; Muir KW; Paciucci A; Papa F; Roncacci S; Sander D; Sander K; Smith CJ; Stefanini A; Weber D
    Stroke; 2005 Jun; 36(6):1316-29. PubMed ID: 15879341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomics study on the effects of Buchang Naoxintong capsules for treating cerebral ischemia in rats using UPLC-Q/TOF-MS.
    Liu M; Liu X; Wang H; Xiao H; Jing F; Tang L; Li D; Zhang Y; Wu H; Yang H
    J Ethnopharmacol; 2016 Mar; 180():1-11. PubMed ID: 26806568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomics for Biomarker Discovery: Moving to the Clinic.
    Zhang A; Sun H; Yan G; Wang P; Wang X
    Biomed Res Int; 2015; 2015():354671. PubMed ID: 26090402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aetiological blood biomarkers of ischaemic stroke.
    Sonderer J; Katan Kahles M
    Swiss Med Wkly; 2015; 145():w14138. PubMed ID: 26024210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The penumbra, therapeutic time window and acute ischaemic stroke.
    Fisher M; Takano K
    Baillieres Clin Neurol; 1995 Aug; 4(2):279-95. PubMed ID: 7496621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.